With exclusion of the CCND1 amplification, which was equally distributed between cell lines from primary and metastatic melanomas [2/8 (25%) vs. 6/24 (25%)], cMET and cKIT amplifications were detected only in cell lines from melanoma metastases (Table 2; Supplementary Table 1). The gene discussed is KIT; the disease is melanoma.